Skip to main content
Year archive

ALTERITY THERAPEUTICS LIMITED — 2025 filings

All 99 regulatory filings released by ALTERITY THERAPEUTICS LIMITED (ATH) in 2025, sourced directly from the official regulator.

99 Filings
2025 Period
2025 filings (99)
Filing Released Lang
Final Director's Interest Notice - Kempler 2 pages 4.7KB
Director's Dealing
2025-11-23 English
Final Director's Interest Notice - Meltzer 2 pages 4.4KB
Director's Dealing
2025-11-23 English
Initial Director's Interest Notice - Stamler 2 pages 4.4KB
Director's Dealing
2025-11-23 English
Initial Director's Interest Notice - Barbaczy 2 pages 251.5KB
Director's Dealing
2025-11-23 English
Alterity Board Changes 3 pages 216.8KB
Board/Management Information
2025-11-20 English
Chairman's Address 2025 Annual General Meeting 3 pages 153.8KB
AGM Information
2025-11-20 English
Presentation to Annual General Meeting 24 pages 1.4MB
Investor Presentation
2025-11-20 English
Results of Meeting 4 pages 259.9KB
Declaration of Voting Results & Voting Rights Announcements
2025-11-20 English
Disclosure under Takeovers Panel GN 20 2 pages 236.9KB
Major Shareholding Notification
2025-11-12 English
Alterity to Present at the Bell Potter Healthcare Conference 3 pages 185.1KB
Investor Presentation
2025-11-11 English
Alterity Presents Promising ATH434 Impact at AAS Symposium 5 pages 234.3KB
Investor Presentation
2025-11-09 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 464.7KB
Interim / Quarterly Report
2025-10-30 English
Notice of Annual General Meeting/Proxy Form 36 pages 801.5KB
AGM Information
2025-10-20 English
Change in substantial holding 4 pages 256.4KB
Major Shareholding Notification
2025-10-13 English
Alterity Presents Positive ATH434 Data at 2025 MDS Congress 6 pages 249.6KB
Investor Presentation
2025-10-08 English
Alterity to Deliver Multiple Presentations at MDS Conference 4 pages 228.9KB
Investor Presentation
2025-10-01 English
Alterity Reports New Commercial Assessment for ATH434 in MSA 42 pages 2.5MB
Investor Presentation
2025-09-28 English
Date of AGM and Closing Date for Director Nominations 1
AGM Information
2025-09-22 English
Change in substantial holding 6 pages 585.7KB
Major Shareholding Notification
2025-09-16 English
Notification of cessation of securities - ATH 5 pages 16.1KB
Share Issue/Capital Change
2025-09-16 English
Change of Director's Interest Notice x 4 12 pages 70.1KB
Director's Dealing
2025-09-16 English
Application for quotation of securities - ATH 8 pages 20.7KB
Share Issue/Capital Change
2025-09-14 English
Notice Under Section 708A 1 page 99.7KB
Share Issue/Capital Change
2025-09-14 English
Alterity Presents Phase 2 Data at US Neurology Meeting 4 pages 221.9KB
Regulatory Filings
2025-09-14 English
Alterity Raises A$20.0 million in Strategic Placement 3 pages 187.8KB
Capital/Financing Update
2025-09-07 English
Proposed issue of securities - ATH 5 pages 18.1KB
Capital/Financing Update
2025-09-07 English
Trading Halt 2 pages 293.5KB
Capital/Financing Update
2025-09-03 English
Alterity Therapeutics Filed Form 20-F and XBRL Data with SEC 2 pages 180.5KB
Report Publication Announcement
2025-09-01 English
Alterity Therapeutics to Present at the Biotech Showcase 3 pages 239.6KB
Investor Presentation
2025-08-31 English
Appendix 4E and 2025 Annual Report 143 pages 1.9MB
Annual Report
2025-08-28 English
Appendix 4G 12 pages 477.6KB
Governance Information
2025-08-28 English
Corporate Governance Statement 15 pages 279.7KB
Governance Information
2025-08-28 English
Application for quotation of securities - ATH 8 pages 20.6KB
Share Issue/Capital Change
2025-08-21 English
Notification regarding unquoted securities - ATH 6 pages 19.5KB
Share Issue/Capital Change
2025-08-14 English
Notification regarding unquoted securities - ATH 7 pages 21.1KB
Share Issue/Capital Change
2025-08-14 English
Response to ASX Query Letters 18 pages 750.0KB
Regulatory Filings
2025-08-03 English
Updated Corporate Presentation 35 pages 1.8MB
Investor Presentation
2025-07-30 English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 456.8KB
Interim / Quarterly Report
2025-07-29 English
Change in substantial holding 6 pages 588.8KB
Major Shareholding Notification
2025-07-27 English
Positive ATH434 Results from Open-Label Phase 2 Trial in MSA 7 pages 275.3KB
Regulatory Filings
2025-07-27 English
Peer-Reviewed Publication on Novel MRI Endpoint from bioMUSE 4 pages 245.2KB
Regulatory Filings
2025-07-23 English
Application for quotation of securities - ATH 6 pages 18.4KB
Share Issue/Capital Change
2025-07-20 English
Application for quotation of securities - ATH 6 pages 18.9KB
Share Issue/Capital Change
2025-07-16 English
Response to ASX Price Query 4 pages 325.7KB
Regulatory Filings
2025-07-13 English
Change in substantial holding 6 pages 401.4KB
Major Shareholding Notification
2025-07-06 English
Notification regarding unquoted securities - ATH 6 pages 19.5KB
Share Issue/Capital Change
2025-07-02 English
Notification of cessation of securities - ATH 4 pages 15.5KB
Regulatory Filings
2025-06-29 English
Alterity CEO to Provide Corporate Update on ATH434 3 pages 187.5KB
Investor Presentation
2025-06-22 English
Change in substantial holding 6 pages 472.1KB
Major Shareholding Notification
2025-05-22 English
Change in substantial holding 6 pages 470.4KB
Major Shareholding Notification
2025-05-11 English
Alterity Prominently Featured at International MSA Congress 6 pages 272.1KB
Investor Presentation
2025-05-11 English
Alterity Phase 2 Data to be Featured at MSA Congress 5 pages 229.1KB
Investor Presentation
2025-05-06 English
Alterity Granted U.S. FDA Fast Track Designation for ATH434 5 pages 255.4KB
Regulatory Filings
2025-05-04 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 439.2KB
Interim / Quarterly Report
2025-04-29 English
Change of Director's Interest Notice x 3 9 pages 24.1KB
Director's Dealing
2025-04-28 English
Alterity Phase 2 Presentation at MSA Symposium 2025 24 pages 1.3MB
Investor Presentation
2025-04-27 English
Updated Corporate Presentation 35 pages 1.4MB
Investor Presentation
2025-04-21 English
Application for quotation of securities - ATH 7 pages 21.1KB
Share Issue/Capital Change
2025-04-21 English
New Options - Top 20 Holders and Range of Units 3 pages 90.1KB
Major Shareholding Notification
2025-04-21 English
Options Prospectus 22 pages 577.5KB
Capital/Financing Update
2025-04-16 English
Alterity Presents Encouraging New Phase 2 Data in MSA 6 pages 235.5KB
Investor Presentation
2025-04-09 English
Alterity Phase 2 Presentation at AAN 2025 16 pages 1.0MB
Investor Presentation
2025-04-09 English
Change of Director's Interest Notice x 3 8 pages 22.7KB
Director's Dealing
2025-04-08 English
Change in substantial holding 6 pages 398.3KB
Major Shareholding Notification
2025-04-07 English
Becoming a substantial holder 5 pages 99.0KB
Major Shareholding Notification
2025-04-07 English
Application for quotation of securities - ATH 6 pages 18.6KB
Capital/Financing Update
2025-04-06 English
Notice Under Section 708A 1 page 99.7KB
Capital/Financing Update
2025-04-06 English
Completion of Placement 3 pages 207.2KB
Capital/Financing Update
2025-04-06 English
Alterity to Deliver Oral Presentation of ATH434 Trial at AAN 4 pages 218.1KB
Investor Presentation
2025-04-02 English
Results of Meeting 2 pages 27.3KB
Declaration of Voting Results & Voting Rights Announcements
2025-03-30 English
Alterity Completes Last Patient Visit in Open-Label Trial 4 pages 217.4KB
Regulatory Filings
2025-03-26 English
Ceasing to be a substantial holder 4 pages 780.0KB
Major Shareholding Notification
2025-03-23 English
Application for quotation of securities - ATH 6 pages 18.3KB
Share Issue/Capital Change
2025-03-13 English
Becoming a substantial holder 6 pages 977.9KB
Major Shareholding Notification
2025-03-12 English
Half Yearly Report and Accounts 28 pages 948.5KB
Interim / Quarterly Report
2025-02-27 English
Notice of Extraordinary General Meeting/Proxy Form 23 pages 559.4KB
Proxy Solicitation & Information Statement
2025-02-27 English
Proposed issue of securities - ATH 5 pages 19.4KB
Capital/Financing Update
2025-02-23 English
Change in substantial holding 6 pages 472.0KB
Major Shareholding Notification
2025-02-18 English
Application for quotation of securities - ATH 6 pages 18.7KB
Share Issue/Capital Change
2025-02-16 English
Notice Under Section 708A 1 page 103.8KB
Capital/Financing Update
2025-02-16 English
Alterity raises A$40m to Advance ATH434 Development in MSA 4 pages 197.8KB
Capital/Financing Update
2025-02-09 English
Proposed issue of securities - ATH 6 pages 22.2KB
Capital/Financing Update
2025-02-09 English
Ceasing to be a substantial holder 4 pages 360.3KB
Major Shareholding Notification
2025-02-06 English
Becoming a substantial holder 5 pages 453.8KB
Major Shareholding Notification
2025-02-05 English
Trading Halt 2 pages 284.7KB
Capital/Financing Update
2025-02-05 English
Change in substantial holding 6 pages 527.4KB
Major Shareholding Notification
2025-02-04 English
Disclosure under Takeovers Panel GN 20 3 pages 332.3KB
Major Shareholding Notification
2025-02-04 English
Application for quotation of securities - ATH 6 pages 18.4KB
Share Issue/Capital Change
2025-02-03 English
Notice Under Section 708A 1 page 101.3KB
Capital/Financing Update
2025-02-03 English
Alterity Raises Funds for ATH434 BD and Clinical Activities 3 pages 211.0KB
Capital/Financing Update
2025-02-02 English
Proposed issue of securities - ATH 5 pages 17.5KB
Share Issue/Capital Change
2025-02-02 English
Positive ATH434 Phase 2 Results Led By Clinical Efficacy 7 pages 292.1KB
Regulatory Filings
2025-01-29 English
ATH434-201 Phase 2 Topline Results Presentation 26 pages 2.0MB
Investor Presentation
2025-01-29 English
Application for quotation of securities - ATH 6 pages 18.5KB
Share Issue/Capital Change
2025-01-29 English
Trading Halt 2 pages 285.5KB
Regulatory Filings
2025-01-27 English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 483.8KB
Interim / Quarterly Report
2025-01-23 English
Application for quotation of securities - ATH 6 pages 18.3KB
Share Issue/Capital Change
2025-01-21 English
ATH shareholder newsletter January 2025 3 pages 188.3KB
Investor Presentation
2025-01-16 English
Change of Director's Interest Notice x 4 8 pages 415.3KB
Director's Dealing
2025-01-05 English